Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures.
Jeong, Y
Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures. [electronic resource] - Journal of viral hepatitis 11 2018 - 1251-1259 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2893
10.1111/jvh.12932 doi
Aged
Antiviral Agents--therapeutic use
Carbamates
Cell Line, Tumor
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Genotype
Hepacivirus--drug effects
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--therapeutic use
Isoquinolines--therapeutic use
Male
Middle Aged
Mutation
Pyrrolidines
RNA, Viral--biosynthesis
Sulfonamides--therapeutic use
Treatment Failure
Valine--analogs & derivatives
Viral Nonstructural Proteins--genetics
Virus Assembly--genetics
Virus Replication--genetics
Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures. [electronic resource] - Journal of viral hepatitis 11 2018 - 1251-1259 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2893
10.1111/jvh.12932 doi
Aged
Antiviral Agents--therapeutic use
Carbamates
Cell Line, Tumor
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Genotype
Hepacivirus--drug effects
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--therapeutic use
Isoquinolines--therapeutic use
Male
Middle Aged
Mutation
Pyrrolidines
RNA, Viral--biosynthesis
Sulfonamides--therapeutic use
Treatment Failure
Valine--analogs & derivatives
Viral Nonstructural Proteins--genetics
Virus Assembly--genetics
Virus Replication--genetics